Answers are grounded in this paper and cite their sources.
Background Infective endocarditis (IE) in patients with liver cirrhosis is poorly characterized, and the impact of cirrhosis severity on management and outcomes remains unclear. We aimed to describe the epidemiological, clinical, microbiological, therapeutic, and prognostic features of IE in patients with cirrhosis compared to controls without cirrhosis. Methods We conducted a retrospective bicentric cohort study including consecutive patients with definite or possible IE. Patients with cirrhosis were matched 1:4 with controls without cirrhosis on age, sex, center, comorbidities, prosthetic valve status, and causative microorganism. Cirrhosis severity was assessed using the Child–Pugh classification. Multivariable analyses were performed to identify factors associated with mortality. Results Among 1,550 screened IE episodes, 79 patients (5.1%) had cirrhosis and were matched to 316 controls. Baseline characteristics and IE predisposing conditions were similar between groups including microbiology. Cardiac surgery was performed less often in patients with cirrhosis than in controls (19/79 (24.1%) vs 146/316 (46.2%), p = 0.001). Cirrhosis-related complications were frequent and increased with disease severity, including acute kidney injury (p = 0.033). Ninety-day mortality was higher in patients with cirrhosis than in controls (28/79 [35.4%] vs 42/316 [13.3%], p < 0.001). In multivariable analysis, absence of cardiac surgery (aOR 2.2 ; 95%CI [1.0-4.9]), Child–Pugh B (aOR 2.9, 95% CI 1.1–7.5) and Child–Pugh C cirrhosis (aOR 6.9, 95% CI 2.3–20.6), but not Child–Pugh A (aOR 1.6, 95% CI 0.3–8.9), were independently associated with 90-day mortality. Conclusion IE prognosis in patients with cirrhosis is driven primarily by liver disease severity and associated organ dysfunction.
No takes yet. Share an insight, caveat, or question.
Chauveau et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: